• Latest Posts

New Retinitis Pigmentosa Treatments? This Blood-Retina Chip Could Help!

French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa

These Dissolving Lenses Could Wash Away Glaucoma Patients’ Problems

A London Biotech Aims to Overtake the Dry Eye Syndrome Market

ADVERTISEMENT

Update: French Gene Therapy Yields Longer Term Sight Restoration, Eyes Phase III

Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low

French Gene Therapy to Cure Retinitis Pigmentosa Enters the Clinic

Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year

€40M in Series C for a British Biotech Treating Blindness with Gene Therapy

ADVERTISEMENT